Cancer Registry Software Market Recent Developments Including Software Integrations and New Launches

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cancer Registry Software Market- (By Software Type (Standalone Software, Integrated Software), By Database (Public data, Commercial data), By Deployment Model (Cloud-based, On-premises), By Functionality (Cancer reporting to meet federal regulations, Patient care management, Product outcome evaluation, Medical research and clinical studies), By End-User (Government organisation and third-party administrator, Hospitals and medical practices, Research centres, Pharmaceutical, Biotechnology companies & medical device companies, Private players, Research centres)), Trends, Industry Competition Analysis, Revenue and Forecast To 2035."

Cancer Registry Software Market Size is valued at USD 93.86 Mn in 2025 and is predicted to reach USD 315.08 Mn by the year 2035 at a 13.0% CAGR during the forecast period for 2026 to 2035.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1992

Cancer registries play a critical role in advancing clinical research and improving patient care outcomes. Countries typically utilize a combination of population-based and hospital-based registries to systematically monitor and manage cancer incidence. Population-based registries, often administered by governmental agencies, perform essential functions such as supporting early cancer detection, tracking epidemiological trends, informing prevention strategies, and evaluating treatment outcomes and patient prognoses. These registries provide a cost-effective mechanism for assessing the impact of cancer prevention initiatives, thereby contributing to reductions in disease prevalence across regions. The global emphasis on strengthening cancer control measures has emerged as a significant driver for the expansion of cancer registry systems.

Market growth is anticipated to be supported by factors including the rising incidence of cancer, advancements in healthcare delivery, initiatives to reduce healthcare expenditures, and strategic activities by leading industry participants, including product launches, mergers, and acquisitions. The adoption of innovative, cost-efficient digital solutions is enhancing registry infrastructure and operational efficiency, further promoting market development. Nevertheless, concerns related to patient data security and privacy, coupled with the slow adoption of advanced software technologies by certain healthcare providers, may limit market expansion.

Both public and private registries are increasingly prioritizing investments in sophisticated registry software and initiatives aimed at improving data quality. Additionally, research institutions and pharmaceutical companies are relying more heavily on cancer registries as critical resources for longitudinal data collection in Phase III and IV clinical trials. These developments are expected to strengthen clinical research capabilities, enhance healthcare evaluation, and contribute to a reduction in the overall cancer burden, thereby supporting sustained market growth over the forecast period.

List of Prominent Players in the Cancer Registry Software Market:
• Elekta (Sweden),
• Electronic Registry Systems, Inc. (US),
• Onco, Inc. (US),
• C/NET Solutions (US),
• Rocky Mountain Cancer Data Systems (US),
• McKesson Corporation (US)

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03

Market Dynamics
Drivers:
The global cancer registry software market is experiencing strong growth, primarily driven by initiatives aimed at enhancing healthcare infrastructure and reducing the costs associated with healthcare delivery. Government-led programs focused on cancer prevention, combined with the widespread implementation of cancer registry software, are further supporting market expansion.

The increasing prevalence of cancer-a leading cause of mortality and one of the most common chronic diseases globally-serves as a key growth catalyst. Factors such as changes in dietary patterns, environmental exposures including pollution and tobacco use, and genetic predispositions are contributing to the rising global cancer burden, positioning cancer as the second leading cause of death worldwide.

Challenges:
A significant challenge constraining market growth is the lack of interoperability across diverse healthcare systems. Although cancer registries play a vital role in enhancing patient care by providing accurate and accessible data on treatments, outcomes, and patient histories, fragmented electronic health record (EHR) systems across hospitals and oncology centers create inefficiencies in clinical workflows. The inability to integrate cancer registries seamlessly with EHR platforms limits effective data extraction and sharing, thereby impeding broader adoption of registry software. This interoperability gap is expected to continue constraining market expansion over the forecast period.

Regional Trends:
North America is projected to maintain a dominant market position, driven by ongoing product innovation and a high prevalence of chronic diseases, particularly cancer. Widespread adoption of cancer registry solutions, such as Registry Plus software, facilitates compliance with National Program of Cancer Registries (NPCR) electronic data-sharing requirements while improving operational efficiency, thereby supporting market growth.

The Asia-Pacific region is also anticipated to secure a significant market share, supported by population growth, rapid urbanization, and continued industrial development. Sustained investments in research and development by leading industry participants are expected to further drive market expansion in the region.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1992

Recent Developments:
• In Sept 2022, Nursenav Inc. and Electronic Registry Systems (ERS) Inc. collaborated to connect their two most prominent software products, CRStar and CONNECT. In order to complement the services offered by oncology navigation, this integration made use of cancer registry workflows and data collecting.
• In December 2020, McKesson started Ontada, an oncology technology and insights business that aims to help improve cancer research and care. Ontada was in a unique situation to improve cancer care by allowing deep collaboration between life sciences companies and oncology providers.

Segmentation of Cancer Registry Software Market-
By Software Type
• Standalone Software
• Integrated Software
By Database
• Public data
• Commercial data
By Deployment Model
• Cloud-based
• On-premises
By Functionality
• Cancer reporting to meet federal regulations.
• Patient care management
• Product outcome evaluation
• Medical research and clinical studies
By End-User-
• Government organization and third-party administrator
• Hospitals and medical practices
• Research centers
• Pharmaceutical, Biotechnology companies & medical device companies
• Private players
• Research centers
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

View Overview Report: https://www.insightaceanalytic.com/report/cancer-registry-software-market/1992

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.